Literature DB >> 15113856

p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes.

A Oniscu1, N Sphyris, R G Morris, S Bader, D J Harrison.   

Abstract

AIMS: Colonocytes were derived from wild-type (wt) and p53 deficient mice to investigate p53 dependent and independent death pathways after cisplatin treatment, and the role of p53 in growth regulation of primary, untransformed epithelial cells.
METHODS: Wt and p53 null colonocytes were exposed to cisplatin and DNA synthesis, apoptosis, and p53, p21, and p73 expression were investigated after six, 12, and 24 hours. Major p73 isoforms were identified by reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: Cisplatin treated wt cells exhibited cell cycle arrest, whereas p53 null cells continued to synthesise DNA, although both cell types died. Apoptosis was significantly higher in cisplatin treated wt and p53 null colonocytes than in controls at all timepoints, although apoptosis was lower in cisplatin treated p53 null colonocytes than in wt cells. p53 expression was upregulated in cisplatin treated wt colonocytes. p21 expression was high and remained unchanged in cisplatin treated wt cells, although it was reduced in the absence of p53. p73 was investigated because it could account for p53 independent p21 expression and p53 independent death. RT-PCR detected full length p73alpha. p73 transcript levels remained unchanged, whereas p73 protein accumulated in the nucleus of cisplatin treated cells, irrespective of genotype.
CONCLUSIONS: p53 is essential for cell cycle arrest, but not apoptosis in primary murine colonocytes. Apoptosis is reduced in cisplatin treated p53 null cells. Nuclear accumulation of endogenous p73 after cisplatin treatment suggests a proapoptotic role for p73alpha in the absence of p53 and collaboration with p53 in wt colonocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113856      PMCID: PMC1770307          DOI: 10.1136/jcp.2003.012559

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  42 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

3.  A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa.

Authors:  E D Williams; A P Lowes; D Williams; G T Williams
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

4.  Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.

Authors:  Osamu Ishimoto; Chikashi Kawahara; Kentaro Enjo; Masuo Obinata; Toshihiro Nukiwa; Shuntaro Ikawa
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

Review 5.  TP53 mutation in colorectal cancer.

Authors:  Barry Iacopetta
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

Review 6.  TP53 family members and human cancers.

Authors:  Jean Bénard; Setha Douc-Rasy; Jean-Charles Ahomadegbe
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

7.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

8.  Expression of p73 gene, cell proliferation and apoptosis in breast cancer: Immunohistochemical and clinicopathological study.

Authors:  Tatsuyoshi Yamamoto; Koji Oda; Tomoyuki Kubota; Kou Miyazaki; Yasushi Takenouti; Yuji Nimura; Michinari Hamaguchi; Satoru Matsuda
Journal:  Oncol Rep       Date:  2002 Jul-Aug       Impact factor: 3.906

9.  Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage.

Authors:  M Valeria Catani; Antonio Costanzo; Isabella Savini; Massimo Levrero; Vincenzo de Laurenzi; Jean Y J Wang; Gerry Melino; Luciana Avigliano
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

10.  Comparative analysis of p73 and p53 regulation and effector functions.

Authors:  L Fang; S W Lee; S A Aaronson
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

View more
  3 in total

1.  Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway.

Authors:  Man Jiang; Cong-Yi Wang; Shuang Huang; Tianxin Yang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-11

Review 2.  Platinum Complexes in Colorectal Cancer and Other Solid Tumors.

Authors:  Beate Köberle; Sarah Schoch
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

3.  Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.

Authors:  Juan Liu; Hiroshi Uematsu; Nobuo Tsuchida; Masa-Aki Ikeda
Journal:  Mol Cancer       Date:  2011-07-31       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.